Ing. Jan Šimoník
Researcher I, Department of Biochemistry
correspondence Address:
Kotlářská 267/2, 611 37 Brno
e‑mail: |
---|
Total number of publications: 9
2024
-
Transmembrane glycoprotein GPNMB is a candidate predictive biomarker and potentially a therapeutic target in metastatic renal cell carcinoma
Year: 2024, type: Conference abstract
2023
-
Next generation proteomics identifies a potential protein marker of poor response to tyrosine kinase inhibitors in metastatic renal cell carcinoma
Year: 2023, type: Conference abstract
-
Proteotype classification of localized and metastatic renal cell carcinoma for prognosis and therapy response
Year: 2023, type: Conference abstract
-
Proteotype classification of metastatic and localized renal cell carcinomas for prognosis and therapy response
Year: 2023, type: Conference abstract
-
Proteotypová klasifikace renálního karcinomu
Year: 2023, type:
-
Transmembrane glycoprotein GPNMB is a potential marker of poor response of metastatic renal cell carcinoma to tyrosine kinase receptor inhibitor treatment
Year: 2023, type: Conference abstract
2022
-
DIA-MS identifies proteins associated with a poor response of metastatic renal cell carcinoma to tyrosine kinase inhibitor treatment
Year: 2022, type: Conference abstract
-
Proteiny odpovědné za špatnou terapeutickou odpověď metastatických nádorů ledvin na léčbu tyrosinkinasovými inhibitory
Year: 2022, type: Conference abstract
-
Proteotype classification of renal cell carcinoma for prognosis and therapy response
Year: 2022, type: Conference abstract